Tags

Type your tag names separated by a space and hit enter

Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016.
MMWR Morb Mortal Wkly Rep 2016; 65(3):63-7MM

Abstract

CDC has developed interim guidelines for health care providers in the United States who are caring for infants born to mothers who traveled to or resided in an area with Zika virus transmission during pregnancy. These guidelines include recommendations for the testing and management of these infants. Guidance is subject to change as more information becomes available; the latest information, including answers to commonly asked questions, can be found online (http://www.cdc.gov/zika). Pediatric health care providers should work closely with obstetric providers to identify infants whose mothers were potentially infected with Zika virus during pregnancy (based on travel to or residence in an area with Zika virus transmission [http://wwwnc.cdc.gov/travel/notices]), and review fetal ultrasounds and maternal testing for Zika virus infection (see Interim Guidelines for Pregnant Women During a Zika Virus Outbreak*) (1). Zika virus testing is recommended for 1) infants with microcephaly or intracranial calcifications born to women who traveled to or resided in an area with Zika virus transmission while pregnant; or 2) infants born to mothers with positive or inconclusive test results for Zika virus infection. For infants with laboratory evidence of a possible congenital Zika virus infection, additional clinical evaluation and follow-up is recommended. Health care providers should contact their state or territorial health department to facilitate testing. As an arboviral disease, Zika virus disease is a nationally notifiable condition.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26820387

Citation

Staples, J Erin, et al. "Interim Guidelines for the Evaluation and Testing of Infants With Possible Congenital Zika Virus Infection - United States, 2016." MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 3, 2016, pp. 63-7.
Staples JE, Dziuban EJ, Fischer M, et al. Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(3):63-7.
Staples, J. E., Dziuban, E. J., Fischer, M., Cragan, J. D., Rasmussen, S. A., Cannon, M. J., ... Moore, C. A. (2016). Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 65(3), pp. 63-7. doi:10.15585/mmwr.mm6503e3.
Staples JE, et al. Interim Guidelines for the Evaluation and Testing of Infants With Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):63-7. PubMed PMID: 26820387.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. AU - Staples,J Erin, AU - Dziuban,Eric J, AU - Fischer,Marc, AU - Cragan,Janet D, AU - Rasmussen,Sonja A, AU - Cannon,Michael J, AU - Frey,Meghan T, AU - Renquist,Christina M, AU - Lanciotti,Robert S, AU - Muñoz,Jorge L, AU - Powers,Ann M, AU - Honein,Margaret A, AU - Moore,Cynthia A, Y1 - 2016/01/29/ PY - 2016/1/29/entrez PY - 2016/1/29/pubmed PY - 2016/6/1/medline SP - 63 EP - 7 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 65 IS - 3 N2 - CDC has developed interim guidelines for health care providers in the United States who are caring for infants born to mothers who traveled to or resided in an area with Zika virus transmission during pregnancy. These guidelines include recommendations for the testing and management of these infants. Guidance is subject to change as more information becomes available; the latest information, including answers to commonly asked questions, can be found online (http://www.cdc.gov/zika). Pediatric health care providers should work closely with obstetric providers to identify infants whose mothers were potentially infected with Zika virus during pregnancy (based on travel to or residence in an area with Zika virus transmission [http://wwwnc.cdc.gov/travel/notices]), and review fetal ultrasounds and maternal testing for Zika virus infection (see Interim Guidelines for Pregnant Women During a Zika Virus Outbreak*) (1). Zika virus testing is recommended for 1) infants with microcephaly or intracranial calcifications born to women who traveled to or resided in an area with Zika virus transmission while pregnant; or 2) infants born to mothers with positive or inconclusive test results for Zika virus infection. For infants with laboratory evidence of a possible congenital Zika virus infection, additional clinical evaluation and follow-up is recommended. Health care providers should contact their state or territorial health department to facilitate testing. As an arboviral disease, Zika virus disease is a nationally notifiable condition. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/26820387/full_citation L2 - https://dx.doi.org/10.15585/mmwr.mm6503e3 DB - PRIME DP - Unbound Medicine ER -